If case you missed it ..... two articles worth reading.
Editorial - The Treatment of Hepatitis C— An Introduction to the Use of New Medicines
Editorial - The Treatment of Hepatitis C— An Introduction to the Use of New Medicines
09 January 2017
Dtsch Arztebl Int 2017; 114(1-2):9-10 ; DOI: 10.3238/arztebl.2017.0009
Dtsch Arztebl Int 2017; 114(1-2):
An editorial accompanying the article “Treatment Options in Hepatitis C — The Current State of the Art,” by Stefan Zeuzem in this issue of Deutsches Ärzteblatt International
When Deutsches Ärzteblatt International invited me to write an editorial on the treatment of hepatitis C, I hesitated. The topic is evidently relevant not only to gastroenterology, but also to my own specialty, hematology/oncology; it is, however, currently surrounded by emotionally charged debate, sparked by the many new drugs against hepatitis C and their high prices. For both specialties, the availability of new treatment options coincides with major progress in our understanding of the disease. Yet discussions of how patients with hepatitis C should be treated are often narrowly centered on the question of drug costs, and the views expressed on the matter are often rigid and partisan. We can learn much from the way the new drugs for hepatitis C have been dealt with up to now.
Continue to full text article HTML, or Download PDF-Version
No comments:
Post a Comment